Weekly Digest – January 2025 Weekly Digest – January 2025 30 Dec 2024: ADC Therapeutics announces completion of enrollment of Phase 3 confirmatory clinical trial of ZYNLONTA® in combination with rituximab in 2L+ DLBCL ADC Therapeutics has completed enrollment in […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id